Ampliphi Biosciences Corp (NYSEAMERICAN:APHB – Get Free Report)’s stock price crossed below its 50 day moving average during trading on Friday . The stock has a 50 day moving average of $2.00 and traded as low as $1.65. Ampliphi Biosciences shares last traded at $1.65, with a volume of 6,450 shares traded.
Ampliphi Biosciences Stock Performance
The company has a 50-day moving average price of $2.00.
About Ampliphi Biosciences
AmpliPhi Biosciences Corporation, a biotechnology company, focuses on the development of therapies for antibiotic-resistant infections using bacteriophage-based technology. The company is involved in developing AB-SA01 for the treatment of staphylococcus aureus (S. aureus) infections; and AB-PA01 for the treatment of pseudomonas aeruginosa (P.
Further Reading
- Five stocks we like better than Ampliphi Biosciences
- 3 Grocery Stocks That Can Help Take a Bite Out of Inflation
- Why Dollar Tree’s Family Dollar Sale Could Spark a Comeback
- Trading Halts Explained
- JPMorgan: The ‘NVIDIA of Banking’ Poised for More Gains?
- Best Stocks Under $5.00
- Buy the Chewy Stock Reversal? Here’s Why Now Is the Time
Receive News & Ratings for Ampliphi Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ampliphi Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.
